Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
HUTCHMED (China) Limited | H7T2 | Jun 13, 2024 | 3.36 | +9.80 |
Hybrigenics | 3HB | Jun 13, 2024 | 0.01 | +63.64 |
Hyloris Pharmaceuticals SA | 52U | Jun 13, 2024 | 11.40 | 0.00 |
Immupharma Plc | 25I | Jun 13, 2024 | 0.02 | +34.38 |
Immutep Limited | YP1B | Jun 13, 2024 | 0.23 | +1.77 |
Inhibrx, Inc. | 1RK | Jun 13, 2024 | 31.00 | 0.00 |
Innovent Biologics Inc | 6IB | Jun 13, 2024 | 4.10 | +3.02 |
Inventiva S.A. - American Depository Shares | 6IVA | Jun 13, 2024 | 2.96 | +0.68 |
Ixico Plc | PYPB | Jun 13, 2024 | 0.08 | -1.85 |
Legend Biotech Corporation - American Depositary Shares | 9LB | Jun 13, 2024 | 40.60 | -3.79 |
Mabion S.A. | 272 | Jun 13, 2024 | 3.99 | +0.89 |
Medesis Pharma S.A. | 76D | Jun 13, 2024 | 0.90 | -1.10 |
Medmira Inc | 47M | Jun 13, 2024 | 0.05 | -6.12 |
Memphasys Limited | IG7 | Jun 13, 2024 | 0.00 | -66.67 |
Mesoblast Ltd | LWB | Jun 13, 2024 | 0.68 | +7.14 |
Nanocarrier Co Ltd | 3NQ | Jun 13, 2024 | 0.70 | -2.78 |
NetScientific plc | NTK1 | Jun 13, 2024 | 0.71 | -2.07 |
Newron Pharmaceuticals Spa. | NP5 | Jun 13, 2024 | 10.44 | +0.58 |
Nuformix plc | 1RT | Jun 13, 2024 | 0.00 | 0.00 |
Ocumension Therapeutics | 5DG | Jun 13, 2024 | 0.76 | -1.31 |
Oncimmune Holdings plc | OCY | Jun 13, 2024 | 0.12 | -4.69 |
Oncoarendi Therapeutics SA | 1B1 | Jun 13, 2024 | 3.15 | -1.25 |
Oncotherpapy Science Inc | 30O | Jun 13, 2024 | 0.17 | +36.80 |
Open Orphan plc | CRO | Jun 13, 2024 | 0.31 | +2.61 |
Opthea Limited | UKJ | Jun 13, 2024 | 0.27 | 0.00 |
OptiBiotix Health plc | OB3 | Jun 13, 2024 | 0.19 | +0.53 |
Oric Pharmaceuticals, Inc. | 4TZ | Jun 13, 2024 | 7.05 | -4.08 |
Oxford BioDynamics plc | LMQ | Jun 13, 2024 | 0.05 | +4.04 |
Oxford Biomedica | OXOA | Jun 13, 2024 | 3.60 | -2.70 |
Pharmaron Beijing Co Ltd | 17Q1 | Jun 13, 2024 | 1.13 | -0.88 |
|
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.